OneDigital Investment Advisors LLC Has $235,000 Stake in Bruker Co. (NASDAQ:BRKR)

OneDigital Investment Advisors LLC grew its holdings in shares of Bruker Co. (NASDAQ:BRKR) by 9.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,002 shares of the medical research company’s stock after acquiring an additional 362 shares during the quarter. OneDigital Investment Advisors LLC’s holdings in Bruker were worth $235,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Eagle Bay Advisors LLC increased its stake in shares of Bruker by 2,324.1% in the fourth quarter. Eagle Bay Advisors LLC now owns 703 shares of the medical research company’s stock valued at $41,000 after buying an additional 674 shares during the period. UMB Bank n.a. increased its stake in shares of Bruker by 37.5% in the fourth quarter. UMB Bank n.a. now owns 909 shares of the medical research company’s stock valued at $53,000 after buying an additional 248 shares during the period. GAMMA Investing LLC increased its stake in shares of Bruker by 47.5% in the fourth quarter. GAMMA Investing LLC now owns 1,279 shares of the medical research company’s stock valued at $75,000 after buying an additional 412 shares during the period. Quadrant Capital Group LLC increased its stake in shares of Bruker by 18.2% in the fourth quarter. Quadrant Capital Group LLC now owns 1,273 shares of the medical research company’s stock valued at $75,000 after buying an additional 196 shares during the period. Finally, EverSource Wealth Advisors LLC increased its stake in shares of Bruker by 41.5% in the fourth quarter. EverSource Wealth Advisors LLC now owns 1,330 shares of the medical research company’s stock valued at $78,000 after buying an additional 390 shares during the period. Institutional investors and hedge funds own 79.52% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. Guggenheim reaffirmed a “buy” rating on shares of Bruker in a research note on Monday, February 24th. Stifel Nicolaus decreased their target price on shares of Bruker from $70.00 to $57.00 and set a “hold” rating for the company in a research report on Friday, February 14th. Barclays decreased their target price on shares of Bruker from $60.00 to $50.00 and set an “overweight” rating for the company in a research report on Thursday, April 10th. Wells Fargo & Company decreased their target price on shares of Bruker from $75.00 to $60.00 and set an “overweight” rating for the company in a research report on Thursday, April 17th. Finally, Citigroup decreased their target price on shares of Bruker from $75.00 to $50.00 and set a “buy” rating for the company in a research report on Monday, April 7th. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, Bruker currently has an average rating of “Moderate Buy” and an average target price of $65.00.

Bruker Stock Up 1.5 %

BRKR opened at $39.66 on Tuesday. The company has a quick ratio of 0.77, a current ratio of 1.60 and a debt-to-equity ratio of 1.15. The stock has a market cap of $6.01 billion, a price-to-earnings ratio of 52.18, a PEG ratio of 2.16 and a beta of 1.18. Bruker Co. has a twelve month low of $34.10 and a twelve month high of $82.04. The company’s 50-day moving average price is $42.99 and its two-hundred day moving average price is $52.45.

Bruker (NASDAQ:BRKR) last announced its quarterly earnings results on Thursday, February 13th. The medical research company reported $0.76 EPS for the quarter, beating analysts’ consensus estimates of $0.75 by $0.01. Bruker had a net margin of 3.36% and a return on equity of 21.01%. As a group, equities analysts expect that Bruker Co. will post 2.69 earnings per share for the current year.

Bruker Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 28th. Stockholders of record on Monday, March 17th were issued a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.50%. The ex-dividend date of this dividend was Monday, March 17th. Bruker’s payout ratio is 26.32%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.